Lg Chem
Clinical trials sponsored by Lg Chem, explained in plain language.
-
New gout pill shows promise in lowering uric acid levels
Disease control CompletedThis study tested a new drug called LC350189 in 156 adults with gout and high uric acid. The goal was to see if it could safely lower uric acid levels over 12 weeks. Participants received one of three doses of the drug, a placebo, or an active comparator. The main measure was the…
Phase: PHASE2 • Sponsor: LG Chem • Aim: Disease control
Last updated May 17, 2026 02:05 UTC
-
New gout drug shows promise in major trial
Disease control CompletedThis study tested a new medicine called tigulixostat in 354 adults with gout and high uric acid levels. The goal was to see if taking the drug for 6 months could safely lower uric acid below a target level. Participants received either one of three doses of tigulixostat or a plac…
Phase: PHASE3 • Sponsor: LG Chem • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New triple combo pill shows promise for diabetes control
Disease control CompletedThis study looked at how well and how safely a triple combination of diabetes drugs (zemidapa and metformin) works for people with type 2 diabetes. Over 2,000 patients who were already on other diabetes medicines took part. The main goal was to see if their blood sugar levels imp…
Sponsor: LG Chem • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Diabetes combo pill put to the test in healthy volunteers
Knowledge-focused CompletedThis study checked if a single pill containing three diabetes drugs (gemigliptin, dapagliflozin, and metformin) works the same in the body as taking the three drugs separately. It involved 50 healthy adults aged 19 to 50. The goal was to compare how the drugs are absorbed and pro…
Phase: PHASE1 • Sponsor: LG Chem • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC